Do patient- and tumor-related factors predict the peritoneal spread of pancreatic adenocarcinoma?

Autor: Königsrainer I; Department of General, Visceral and Transplant Surgery, University of Tübingen Comprehensive Cancer Center, Hoppe-Seyler-Strasse 3, 72076, Tübingen, Germany, ingmar.koenigsrainer@med.uni-tuebingen.de., Zieker D, Symons S, Horlacher K, Königsrainer A, Beckert S
Jazyk: angličtina
Zdroj: Surgery today [Surg Today] 2014 Feb; Vol. 44 (2), pp. 260-3. Date of Electronic Publication: 2013 Mar 15.
DOI: 10.1007/s00595-013-0546-0
Abstrakt: Purpose: In pancreatic cancer, the presence of peritoneal carcinomatosis (PC) precludes the possibility of a surgical cure, irrespective of the resectability of the primary tumor. However, peritoneal spread cannot be reliably detected radiographically during preoperative tumor staging.
Methods: The pancreatic adenocarcinoma database of the Tübingen Comprehensive Cancer Center included 29 patients in whom PC was incidentally detected during the surgery. These patients were retrospectively compared for patient- and tumor-related factors with 29 randomly selected patients without PC who underwent curative resection.
Results: Clinical jaundice and diarrhea were more frequently present in patients without PC. The CA 19-9 levels were significantly higher in patients with PC compared to those in patients without PC. No other differences were observed in the patient- or tumor-related factors between the two groups.
Conclusion: In pancreatic cancer patients, markedly elevated CA 19-9 levels may serve as surrogate marker for peritoneal dissemination, irrespective of the local resectability of the tumor. In such patients, laparoscopy should be considered as an additional staging tool to rule out peritoneal carcinomatosis.
Databáze: MEDLINE
Externí odkaz: